Microenvironment‐Regulated Hydrogels Prepared with a Brand‐New Small Molecule Cross‐Linker for Stepwise Treatment of Myocardial Infarction DOI Open Access

Yu Wu,

Wen Zhang, Linlin Huang

и другие.

Advanced Healthcare Materials, Год журнала: 2025, Номер unknown

Опубликована: Март 4, 2025

Abstract Despite the development of many injectable hydrogels intended for repair myocardial infarction (MI), their effectiveness is often compromised because they target merely one or two phases MI's pathological progression. Here, a multifunctional hydrogel delivery platform prepared with brand‐new small molecule cross‐linker stepwise treatment MI. The synthesis and reporting novel small‐molecule phenylboronic acid ((N(BA) 3 )) precise molecular structure conducted first time, it successfully utilized polyvinyl alcohol (PVA) dopamine to prepare infarct microenvironmental responsiveness anti‐oxidant. Further, considering multistage MI repair, contains both hyperoside bioactive nanoparticles (EGCG@Hyp&Arg NPs) PLGA microspheres loaded galunisertib (PLGA@Gal Ms). EGCG@Hyp&Arg NPs are rapidly released demonstrate anti‐inflammatory pro‐angiogenesis effects, while in long term, Gal from PLGA@Gal Ms inhibit fibrosis improve cardiac function. Results vitro vivo studies reveal that engineered programmed capabilities anti‐oxidation, reducing inflammation, promoting new blood vessel formation, inhibiting fibrosis, thereby significantly enhancing heart function post‐MI. Overall, this has great potential application as therapeutic strategy

Язык: Английский

Regeneration of infarcted hearts by myocardial infarction-responsive injectable hydrogels with combined anti-apoptosis, anti-inflammatory and pro-angiogenesis properties DOI
Cheng Hu, Wenqi Liu, Linyu Long

и другие.

Biomaterials, Год журнала: 2022, Номер 290, С. 121849 - 121849

Опубликована: Окт. 5, 2022

Язык: Английский

Процитировано

75

Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release DOI
Jing Liu, Horacio Cabral, Peng Mi

и другие.

Advanced Drug Delivery Reviews, Год журнала: 2024, Номер 207, С. 115239 - 115239

Опубликована: Март 3, 2024

Язык: Английский

Процитировано

52

Mitochondrial-targeted and ROS-responsive nanocarrier via nose-to-brain pathway for ischemic stroke treatment DOI Creative Commons

Yan Zhang,

Haiyun Zhang,

Faquan Zhao

и другие.

Acta Pharmaceutica Sinica B, Год журнала: 2023, Номер 13(12), С. 5107 - 5120

Опубликована: Июнь 20, 2023

Oxidative stress injury and mitochondrial dysfunction are major obstacles to neurological functional recovery after ischemic stroke. The development of new approaches simultaneously diminish oxidative resist is urgently needed. Inspired by the overproduced reactive oxygen species (ROS) at neuron mitochondria, multifunctional nanoparticles with ROS-responsiveness mitochondrial-targeted (SPNPs) were engineered, achieving specific targeting delivery controllable drug release penumbra. Due nose-to-brain pathway, SPNPs which encapsulated in a thermo-sensitive gel intranasal administration directly delivered penumbra bypassing blood‒brain barrier (BBB) enhancing efficiency. potential for stroke treatment was systematically evaluated

Язык: Английский

Процитировано

51

Revitalizing Ancient Mitochondria with Nano‐Strategies: Mitochondria‐Remedying Nanodrugs Concentrate on Disease Control DOI

Xingyu Long,

Min Liu,

Yayun Nan

и другие.

Advanced Materials, Год журнала: 2024, Номер 36(18)

Опубликована: Янв. 15, 2024

Abstract Mitochondria, widely known as the energy factories of eukaryotic cells, have a myriad vital functions across diverse cellular processes. Dysfunctions within mitochondria serve catalysts for various diseases, prompting widespread demise. Mounting research on remedying damaged indicates that constitute valuable target therapeutic intervention against diseases. But less clinical practice and lower recovery rate imply limitation traditional drugs, which need further breakthrough. Nanotechnology has approached favorable regiospecific biodistribution high efficacy by capitalizing excellent nanomaterials targeting drug delivery. Mitochondria‐remedying nanodrugs achieved ideal effects. This review elucidates significance in cells organs, while also compiling mortality data related Correspondingly, nanodrug‐mediate strategies applicable mitochondria‐remedying disease are detailed, with full understanding roles dysfunction advantages nanodrugs. In addition, future challenges directions discussed. conclusion, this provides comprehensive insights into design development nanodrugs, aiming to help scientists who desire extend their fields engage interdisciplinary subject.

Язык: Английский

Процитировано

29

Advanced Cardiac Patches for the Treatment of Myocardial Infarction DOI
Tailuo Liu, Ying Hao,

Zixuan Zhang

и другие.

Circulation, Год журнала: 2024, Номер 149(25), С. 2002 - 2020

Опубликована: Июнь 17, 2024

Myocardial infarction is a cardiovascular disease characterized by high incidence rate and mortality. It leads to various cardiac pathophysiological changes, including ischemia/reperfusion injury, inflammation, fibrosis, ventricular remodeling, which ultimately result in heart failure pose significant threat global health. Although clinical reperfusion therapies conventional pharmacological interventions improve emergency survival rates short-term prognoses, they are still limited providing long-lasting improvements function or reversing pathological progression. Recently, patches have gained considerable attention as promising therapy for myocardial infarction. These consist of scaffolds loaded therapeutic agents that provide mechanical reinforcement, synchronous electrical conduction, localized delivery within the infarct zone promote restoration. This review elucidates progression from failure, highlighting targets patches. The considers primary scaffold materials, synthetic, natural, conductive prevalent fabrication techniques optimal properties patch, well advanced strategies. Last, current limitations prospects patch research considered, with goal shedding light on innovative products poised application.

Язык: Английский

Процитировано

23

Mitigation of ischemia/reperfusion injury via Selenium nanoparticles: suppression of STAT1 to inhibit cardiomyocyte oxidative stress and inflammation DOI

Chunxia Chen,

Jingjing Ma, Sophia Xiaoxia Duan

и другие.

Biomaterials, Год журнала: 2025, Номер 318, С. 123119 - 123119

Опубликована: Янв. 25, 2025

Язык: Английский

Процитировано

2

Colon-Targeting Angelica sinensis Polysaccharide Nanoparticles with Dual Responsiveness for Alleviation of Ulcerative Colitis DOI
Yu Xu, Beiwei Zhu, Rong Sun

и другие.

ACS Applied Materials & Interfaces, Год журнала: 2023, Номер 15(22), С. 26298 - 26315

Опубликована: Май 26, 2023

Intestinal immune dysfunction and gut microbiota dysbiosis are critically causative factors in the pathogenesis of ulcerative colitis (UC); however, current first-line drugs for UC treatment clinics often remain great challenges due to their nontargeting therapeutic efficacy severe side effects. In study, colon-targeting nanoparticles based on Angelica sinensis polysaccharide with pH- redox-responsiveness were fabricated specifically release naturally active compound ginsenoside Rh2 colonic inflammatory site, which greatly alleviated symptoms improved microbial homeostasis. These dual responsive Rh2-loaded (Rh2/LA-UASP NPs) a particle size 117.00 ± 4.80 nm prepared using polymer LA-UASP obtained by grafting A. urocanic acid α-lipoic (α-LA). As expected, these Rh2/LA-UASP NPs achieved redox-responsive drug at pH 5.5 10 mM GSH. The stability, biocompatibility, vivo safety experiments exhibited had excellent ability significant accumulation colon. Meanwhile, could escape from lysosomes be efficiently internalized into intestinal mucosal cells, thereby effectively inhibiting proinflammatory cytokines. animal indicated that significantly integrity mucosa increased colon length compared mice. Additionally, weight loss, histological damage, inflammation level ameliorated. homeostasis flora short-chain fatty acids (SCFAs) after being treated Our study proved pH-and promising candidates treatment.

Язык: Английский

Процитировано

36

Precise Regulation of Inflammation and Oxidative Stress by ROS‐Responsive Prodrug Coated Balloon for Preventing Vascular Restenosis DOI
Jing Zhao,

Jia-Yin Fu,

Fan Jia

и другие.

Advanced Functional Materials, Год журнала: 2023, Номер 33(30)

Опубликована: Апрель 26, 2023

Abstract Vascular restenosis after balloon dilation is largely caused by the over‐proliferation of smooth muscle cells, which triggered and exacerbated local excessive inflammation oxidative stress. The inflammatory stress cause tissue/cell damage, hamper endothelial functions, worsen intimal hyperplasia restenosis. A high level reactive oxygen species (ROS) overproduction regarded as main culprit. Therefore, efficiently inhibiting ROS over‐production or weightily depleting them great significance. Herein, a “ROS‐responsive/scavenging prodrug” introduced into coating for treatment vascular reversible phenylboronic ester‐bearing caffeic acid (CA) macromolecular prodrug (PBC) designed controlled on‐demand dual‐drug release level; released CA 4‐hydroxybenzyl alcohol exhibit efficient antioxidant anti‐inflammatory effects scavenging ROS, thereby regulating microenvironment protecting endothelium functions. To accelerate regeneration, pro‐endothelial microRNA‐126 further introduced. ROS‐responsive/scavenging prodrug/miRNA prevents hyperplasia, alleviates inflammation, improves healing in rat abdominal aorta model, may provide applicative perspectives next‐generation drug‐coated balloons other cardiovascular diseases treatment.

Язык: Английский

Процитировано

35

Enhanced Mitochondrial Targeting and Inhibition of Pyroptosis with Multifunctional Metallopolyphenol Nanoparticles in Intervertebral Disc Degeneration DOI
Hao Zhou, Qiuping Qian, Qizhu Chen

и другие.

Small, Год журнала: 2023, Номер 20(13)

Опубликована: Ноя. 12, 2023

Intervertebral disc degeneration (IVDD) is a significant contributor to low back pain, characterized by excessive reactive oxygen species generation and inflammation-induced pyroptosis. Unfortunately, there are currently no specific molecules or materials available effectively delay IVDD. This study develops multifunctional full name of PG@Cu nanoparticle network (PG@Cu). A designed pentapeptide, bonded on nanoparticles via Schiff base bond, imparts multifunctionality the metal polyphenol particles (PG@Cu-FP). PG@Cu-FP exhibits enhanced escape from lysosomal capture, enabling efficient targeting mitochondria scavenge excess species. The scavenging activity against originates polyphenol-based structures within nanoparticles. Furthermore, Pyroptosis blocked inhibiting Gasdermin mediated pore formation membrane rupture. successfully reduces activation nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 inflammasome protein (Gasdermin D, GSDMD) oligomerization, leading reduced expression Nod-like receptors. multifaceted approach demonstrates higher efficiency in Pyroptosis. Experimental results confirm that preserves height, retains water content, tissue structure. These findings highlight potential improving IVDD provide novel insights for future research treatments.

Язык: Английский

Процитировано

27

Application research of novel peptide mitochondrial-targeted antioxidant SS-31 in mitigating mitochondrial dysfunction DOI
Xingrong Du, Qin Zeng,

Yunchang Luo

и другие.

Mitochondrion, Год журнала: 2024, Номер 75, С. 101846 - 101846

Опубликована: Янв. 18, 2024

Язык: Английский

Процитировано

10